Drug profile · INN
pegaptanib sodium
MACUGEN
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
pegaptanib sodium (MACUGEN) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravitreal. Current US regulatory status: approved.
Key facts
INN pegaptanib sodium
Brand MACUGEN
Route INTRAVITREAL
Formulation INJECTABLE
Frequently asked questions
What is pegaptanib sodium?
pegaptanib sodium (MACUGEN) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravitreal. Current US regulatory status: approved.
What is the brand name for pegaptanib sodium?
MACUGEN is a marketed brand name for pegaptanib sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pegaptanib sodium?
pegaptanib sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.